Press "Enter" to skip to content

Tag: vaccines

Updated COVID vaccine 71% effective against hospitalization for older adults

The estimated effectiveness of the updated COVID-19 vaccine among people aged 60 and older in the Netherlands was 70.7% against hospitalization and 73.3% against intensive care unit (ICU) admission in fall and early winter 2023, according to a study published yesterday in Eurosurveillance.

Researchers at the National Institute for Public Health and the Environment and University Medical Center Utrecht parsed data on hospitalizations with admission dates from October to December to estimate the effectiveness of the XBB.1.5 Pfizer/BioNTech COVID-19 vaccine among recipients of at least one previous vaccination. The study included 2,050 hospitalized adults aged 60 and older, 14.4% of whom had received the 2023 COVID-19 vaccine.

Comments closed

JN.1 is Canada’s new dominant COVID-19 subvariant. Here’s what to know

A new COVID-19 subvariant, known as JN.1, has emerged and is now the prevailing strain across Canada, prompting health experts to caution that it may be more infectious and could even have extra symptoms.

Currently, the subvariant makes up the highest proportion of all COVID-19 variants, accounting for more than half (51.9 per cent) of all infections in Canada, according to the latest data from the Public Health Agency of Canada (PHAC).

JN.1 was first detected in Canada on Oct. 9, and since then has rapidly increased.

Comments closed

Health Canada approves RSV vaccine for maternal immunization

Health Canada has approved a new vaccine geared toward protecting two groups most severely affected by the respiratory syncytial virus (RSV): newborns, who would receive antibodies through maternal immunization, and Canadians over 60.

Pfizer Canada’s bivalent vaccine, called Abrysvo, aims to prevent lower respiratory tract disease caused by the virus.

It is the first RSV vaccine in Canada approved for use in pregnancy to provide protection for infants from birth to six months of age, and the second approved for seniors aged 60 and over.

Comments closed

Opinion: The U.S. is facing the biggest COVID wave since Omicron. Why are we still playing make-believe?

The pandemic is far from over, as evidenced by the rapid rise to global dominance of the JN.1 variant of SARS-CoV-2. This variant is a derivative of BA.2.86, the only other strain that has carried more than 30 new mutations in the spike protein since Omicron first came on the scene more than two years ago. This should have warranted designation by the World Health Organization as a variant of concern with a Greek letter, such as Pi.

By wastewater levels, JN.1 is now associated with the second-biggest wave of infections in the United States in the pandemic, after Omicron. We have lost the ability to track the actual number of infections since most people either test at home or don’t even test at all, but the very high wastewater levels of the virus indicate about 2 million Americans are getting infected each day.

Comments closed

Albertans can now book appointments for the updated Novavax vaccine

A limited supply of the updated Novavax vaccine is rolling out in Alberta this week with appointment booking starting Wednesday and shots going into arms as of Friday.

Alberta Health said it has approximately 5,000 doses of the Novavax XBB.1.5 vaccine in stock.

The latest version of the protein-based vaccine was approved by Health Canada in early December.

Comments closed

Respiratory virus activity is high and rising across the United States, CDC data shows

As seasonal virus activity surges across the United States, experts stress the importance of preventive measures – such as masking and vaccination – and the value of treatment for those who do get sick.

Tens of thousands of people have been admitted to hospitals for respiratory illness each week this season. During the week ending December 23, there were more than 29,000 patients admitted with Covid-19, about 15,000 admitted with the flu and thousands more with respiratory syncytial virus, or RSV, according to data from the US Centers for Disease Control and Prevention.

Comments closed

Less than 5% of US preschool cohort hospitalized for COVID were fully vaccinated, study finds

Only 4.5% of a cohort of pediatric COVID-19 patients admitted to US hospitals during the period of Omicron predominance had completed their primary COVID-19 vaccine series, and 7.0% had started but didn’t finish the series, The Pediatric Infectious Disease Journal reports.

The study team, led by Centers for Disease Control and Prevention (CDC) researchers, enrolled 597 vaccine-eligible COVID-19 inpatients aged 8 months to 4 years at 28 hospitals participating in the Overcoming COVID-19 network from September 2022 to May 2023. A total of 62.1% of patients were aged 8 months to 1 year, and 37.9% were aged 2 to 4 years.

Comments closed

Waterloo region’s COVID booster rate lags behind national average

The number of people in Waterloo region who have received their most recent COVID-19 booster shot is just under 11 per cent, which is below the national average.

The region’s vaccination dashboard shows 10.9 per cent of people in the community are up-to-date on their vaccinations as of Dec. 7. The region notes “up to date” means a person has completed their primary series and received a booster dose within the previous six months.

The number of people who have received the updated XBB.1.5 COVID-19 vaccine sits at 10.8 per cent, the region told CBC News in an email.

Comments closed

HHS closes urgent care for two days amid staff shortages, congestion at hospitals

Staffing shortages will close a Hamilton urgent care centre for two days at the same time city emergency departments are becoming increasingly congested with flu, COVID-19 and RSV patients.

With just 13 per cent of Hamiltonians getting a COVID shot in the past six months, local hospitals are bracing for the viral surge to continue climbing over the holidays.

Comments closed

Just 15% of Canadians got updated COVID vaccines this fall, new figures show

Canadians raced to get vaccinated against COVID-19 in the first years of the pandemic, but data suggests there’s far less of a rush to get the latest shots available this fall.

Federal figures show only 15 per cent of the population aged five and up had received an updated vaccine by Dec. 3. And while older age groups had higher uptake rates, more than half of higher-risk older adults still hadn’t gotten a dose by early December, either.

Comments closed

One million Quebecers infected with respiratory viruses

Quebec Health Minister Christian Dubé and his chief public health officer warned Tuesday that the province is facing a major COVID-19 resurgence, coupled with a spike in influenza cases.

“We have a lot of vulnerable people that (are being hospitalized) because of influenza and because of COVID, and they should have been vaccinated,” Dubé said at a news conference.

“I think that the situation over the next few weeks will deteriorate. Let’s be clear about that.”

Comments closed

BioNTech aims to start mRNA vaccine output in Rwanda in 2025

COVID-19 vaccine maker BioNTech (22UAy.DE) aims to start production at its mRNA vaccine factory site in Rwanda in 2025, company officials said on Monday, the first foreign company mRNA vaccine manufacturing site on the continent.

The German company’s first modular factory elements, based on shipping containers, were delivered to the Kigali construction site in March and were then assembled into so-called BioNTainers.

Comments closed

How deadly has COVID been in 2023? Here’s what the Ontario numbers are telling us

More Ontarians have died of COVID-19 in a three-month span this fall than the number of people killed last year on Ontario highways — a comparison one researcher is using to illustrate the stark and ongoing toll of the virus.

Data from Public Health Ontario shows that 574 people died of COVID between Sept. 3 and Dec. 9. Last year, the Ontario Provincial Police reported that about 350 people died in motor vehicle crashes on OPP-patrolled roads.

Comments closed

En plus de la COVID-19, la grippe H1N1 inquiète

Since October, only 16% of Quebecers have been vaccinated against COVID-19, and 17.5% against influenza, this year’s flu (H1N1) that Public Health still fears. The main concern of authorities? The fact that just over one in two Quebecers, among those aged 70 and over, was vaccinated.

Comments closed

Wastewater tests showing high levels of COVID and flu circulating in Waterloo region

When the pandemic started, the province was testing the population and updating the number of COVID cases daily.

But four years on, testing has stalled and the main way to get a snapshot of the COVID picture is through wastewater.

Comments closed

Warning sounded over any moves to defund Covid-19 vaccine

A vaccinologist is warning that restricting access to the Covid-19 vaccine could send a message that it is no longer important.

Covid-19 vaccines and boosters have always been provided free-of-charge – but that funding commitment is due to expire at the end of June next year.

It is possible the Government could move to a more targeted approach like with flu vaccines – where only vulnerable populations get them for free.

Comments closed

Briggs and Rutty: Why we should declare a formal ‘Smallpox Eradication Day’

On Dec. 9, 1979, the Global Commission for the Certification of Smallpox Eradication declared its job complete. This marked the end of a scourge that lasted thousands of years and killed more people than all the wars in recorded history.

Comments closed